Hvas Anne-Mette, Nexo Ebba
Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Denmark.
Haematologica. 2006 Nov;91(11):1506-12. Epub 2006 Oct 17.
We represent an update on diagnosing and treatment of vitamin B12 deficiency. Vitamin B12 deficiency should be suspected in all patients with unexplained anaemia and/or neurological symptoms,as well as in patients at risk of developing vitamin B12 deficiency such as the elderly and patients with intestinal diseases. Measurement of plasma cobalamins is suggested as the primary analysis followed by measurement of plasma methylmalonic acid in unsettled cases. Accumulating evidence indicates that the biologically active cobalamin,plasma holotranscobalamin (holoTC),may be superior to plasma cobalamins, and measurement of holoTC is currently introduced in the clinical setting. No consensus exists concerning evaluation of the cause for vitamin B12 deficiency,and pros and cons on the different tests mainly aiming at evaluation of the function of the gastric mucosa are presented. Once the diagnosis of vitamin B12 deficiency has been confirmed efficient treatment can be ensured either by injections every 2-3 month or by a daily dose of 1 mg vitamin B12.
我们提供了关于维生素B12缺乏症诊断和治疗的最新情况。所有不明原因贫血和/或有神经症状的患者,以及有维生素B12缺乏风险的患者,如老年人和肠道疾病患者,均应怀疑维生素B12缺乏。建议首先检测血浆钴胺素,在诊断不明确的情况下再检测血浆甲基丙二酸。越来越多的证据表明,具有生物活性的钴胺素,即血浆全转钴胺素(holoTC),可能优于血浆钴胺素,目前临床已开始检测holoTC。对于维生素B12缺乏原因的评估尚无共识,本文介绍了主要针对胃黏膜功能评估的不同检测方法的优缺点。一旦确诊维生素B12缺乏,可每2至3个月注射一次,或每日服用1毫克维生素B12,以确保有效治疗。